HIV molecular immunology database
LLNATAIAVAEGTDRVIE
|
gp160(814-831) | human epitope |
IAVAEGTDRVIEVVQRACRA
|
gp160(820-839) | human epitope |
VAEGTDRVIEI
|
gp160(822-832) | human epitope |
VAEGTDRVIEELQRA
|
gp160(822-836) | human epitope |
VAEGTgRVIEgLQRA
|
gp160(822-836) | observed variant |
VAEGTDRVIEgLQRA
|
gp160(822-836) | observed variant |
VAEGTDRVIEEsQRA
|
gp160(822-836) | observed variant |
VAEGTDRiIEEsQRA
|
gp160(822-836) | observed variant |
VAEGTDRVIEaLQRA
|
gp160(822-836) | observed variant |
{t}VAEGTDRVIEELQRA
|
gp160(822-836) | compensatory mutation; inferred escape; processing |
{t}VAEGTDRVIEgLQRA
|
gp160(822-836) | compensatory mutation; inferred escape; processing |
{t}VAEGTDRiIEgLQRA
|
gp160(822-836) | compensatory mutation; inferred escape; processing |
{v}VAEGTDRiIEgLQRv
|
gp160(822-836) | compensatory mutation; inferred escape; processing |
{v}VAEGTDRiIEgLQRA
|
gp160(822-836) | compensatory mutation; inferred escape; processing |
EGTDRIVIEI
|
gp160(824-832) | human epitope |
EATDRILEL
|
gp160(824-832) | human epitope |
TDRVIEVGQRLGRAI
|
gp160(826-840) | A*33:03 human epitope |
TDRVIEVaQRayRAI
|
gp160(826-840) | subtype-specific susceptible form |
DRVIEELQR
|
gp160(827-835) | human epitope |
DRVIEVVQGAYRAIR
|
gp160(827-841) | A2 human epitope |
DRVIEVVQGAYRAIR
|
gp160(827-841) | H-2d, H-2p, H-2q, H-2u mouse epitope |
DRVIEVVQGAYRAIR
|
gp160(827-841) | H-2d, H-2p, H-2q, H-2u mouse epitope |
DRVIEVVQGAYRAIR
|
gp160(827-841) | mouse epitope |
DRVIEVVQGAYRAIR
|
gp160(827-841) | human epitope |
KVIEVAQGA
|
gp160(828-836) | A*02 human epitope |
RVIEVAQRV
|
gp160(828-836) | A*02:01 human epitope |
RVIkVvQRV
|
gp160(828-836) | diminished response |
RVIEVLQRA
|
gp160(828-836) | A*02:01 human epitope |
RVIEVLQRA
|
gp160(828-836) | A*02:01 human epitope |
RVIEVLQAAYR
|
gp160(828-838) | A*11:01 human epitope |
VIEVVQRACRAILHI
|
gp160(829-843) | mouse epitope |
IEVVQRACRAILHIPRRI
|
gp160(830-847) | human epitope |
IEVVQRACRAILHIPRkI
|
gp160(830-847) | observed variant |
IEiVQRACRAILHIPRRI
|
gp160(830-847) | observed variant |
IEVVQRACRAIcHIPRRI
|
gp160(830-847) | observed variant |
IEVVQRACRAIrHIPRRI
|
gp160(830-847) | observed variant |
IEVVQRACRAILHIPRRI
|
gp160(830-847) | human epitope |
IEVVQRACRAIfHIPRRI
|
gp160(830-847) | observed variant |
IEiVQRACRAILHIPRRI
|
gp160(830-847) | observed variant |
IEVVQRACRAILHIPRkI
|
gp160(830-847) | observed variant |
IEVVQRACRAIcHIPRRI
|
gp160(830-847) | observed variant |
IEVVQRACRAIrHIPRRI
|
gp160(830-847) | observed variant |
IEVVQRACRAILHIPRRIRQ
|
gp160(830-849) | human epitope |
IEVVQGAYRAIIRHIPRRIRQGLERI
|
gp160(830-854) | human epitope |
EVAQRAYR
|
gp160(831-838) | A*29 human epitope |
EVAQRAYR
|
gp160(831-838) | A*33:03 human epitope |
EVAQRAYR
|
gp160(831-838) | A*33:03 human epitope |
EVAQRAYR
|
gp160(831-838) | B*08 human epitope |
EVVQRAYR
|
gp160(831-838) | human epitope |
EVaQRAYR
|
gp160(831-838) | observed variant |
VQRTCRAIL
|
gp160(833-841) | human epitope |
LQRAGRAILHIPTRI
|
gp160(833-847) | human epitope |
RAYRAILHI
|
gp160(835-843) | B51 human epitope |
RtfRAILHI
|
gp160(835-843) | observed variant |
RiYRAILHx
|
gp160(835-843) | observed variant |
RAYRAILHI
|
gp160(835-843) | B*51:01 human epitope |
RACRAILHI
|
gp160(835-843) | human epitope |
IGRAILHIPR
|
gp160(836-845) | B*27:05 human epitope |
CRAILHIPR
|
gp160(837-845) | B*27:02 human epitope |
CRAILHIPR
|
gp160(837-845) | B*27:05 human epitope |
YRAIRHIPRRIRQGLERILL
|
gp160(837-856) | A30, B35 human epitope |
YRAIRHIPRRIRQGLERILL
|
gp160(837-856) | B8 human epitope |
YRAIRHIPRRIRQGLERILL
|
gp160(837-856) | human epitope |
YRAIRHIPRRIRQGLERILL
|
gp160(837-856) | human epitope |
CRAILHIPRRIRQGLERALL
|
gp160(837-856) | human epitope |
RAILHIPRRIRQGLERsL
|
gp160(837-856) | observed variant |
RAILHIPtRIRQGLERcL
|
gp160(837-856) | observed variant |
RAIYSIPRR
|
gp160(838-846) | human epitope |
RAILHIPRRIRQGLERAL
|
gp160(838-855) | human epitope |
RAVLNIPTRIRQGLERAL
|
gp160(838-855) | human epitope |
RAVLNvPTRIRQGLERAL
|
gp160(838-855) | observed variant |
RAILHIPRRIRQGLERSL
|
gp160(838-855) | human epitope |
RAILHIPtRIRQGLERcL
|
gp160(838-855) | observed variant |
CRAILHIPRRIRQGLERALL
|
gp160(838-855) | observed variant |
RAILHIPTRIRQGLERCL
|
gp160(838-855) | human epitope |
CRAILHIPrRIRQGLERaLL
|
gp160(838-855) | observed variant |
RAILHIPrRIRQGLERsL
|
gp160(838-855) | observed variant |
ILHIPRRIRQGLERA
|
gp160(840-854) | human epitope |
RNIPIRIRQ
|
gp160(841-849) | human epitope |
LNIPRRIRQGLERAL
|
gp160(841-855) | B*07:02 human epitope |
LHIPTRIRQGLERAL
|
gp160(841-855) | human epitope |
HIPRRIRQGLERALL
|
gp160(842-856) | human epitope |
HIPRRIRQGLERALL
|
gp160(842-856) | human epitope |
IPRRIRQGL
|
gp160(843-851) | A*02:01 human epitope |
IPRRIRQGL
|
gp160(843-851) | A*29 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*07 human, transgenic mouse epitope |
IPRRIRQGf
|
gp160(843-851) | susceptible form |
IPRRIRQGL
|
gp160(843-851) | B*07 human epitope |
IPRRRIRQGL
|
gp160(843-851) | B*07 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*07 human epitope |
IPRRIRQGF
|
gp160(843-851) | B*07 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*07 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*07 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*07:02 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*07:02 human epitope |
IPtRIRQGL
|
gp160(843-851) | literature escape |
IPRRIRQGL
|
gp160(843-851) | B*07:02 human epitope |
IPRRIRQGf
|
gp160(843-851) | subtype-specific susceptible form |
IPRRIRQGL
|
gp160(843-851) | B*07:02 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*07:02 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*41 human epitope |
IPRRIRQGF
|
gp160(843-851) | B*42 human epitope |
lPRRIRQGF
|
gp160(843-851) | observed variant |
IPRRvRQGF
|
gp160(843-851) | observed variant |
IPRRlRQGF
|
gp160(843-851) | observed variant |
IPRRfRQGF
|
gp160(843-851) | observed variant |
IPtRIRQGF
|
gp160(843-851) | observed variant |
IPRRIRQGF
|
gp160(843-851) | B*42:01 human epitope |
IPRRIRQGF
|
gp160(843-851) | B*42:01 human epitope |
IPRRIRQGF
|
gp160(843-851) | B*42:01 human epitope |
vPRRIRQGF
|
gp160(843-851) | escape documented in this paper; observed variant |
IPtRIRQGF
|
gp160(843-851) | escape documented in this paper; observed variant |
IPRRIRQGL
|
gp160(843-851) | B*42:01 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGf
|
gp160(843-851) | subtype-specific susceptible form |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
vPRRIRQGL
|
gp160(843-851) | observed variant |
IPgRIRQGL
|
gp160(843-851) | observed variant |
IPRRkRQGL
|
gp160(843-851) | observed variant |
IPRRIRQGf
|
gp160(843-851) | observed variant |
IPRRIRQGL
|
gp160(843-851) | B7 epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGF
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGf
|
gp160(843-851) | calculated diminished HLA binding; observed variant |
IPtRIRQGL
|
gp160(843-851) | calculated diminished HLA binding; observed variant |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQdL
|
gp160(843-851) | non-susceptible form |
IPtRIRQGL
|
gp160(843-851) | diminished response |
IPRRlRQGL
|
gp160(843-851) | diminished response |
IPtRIRQGf
|
gp160(843-851) | non-susceptible form |
IPRRIRQGL
|
gp160(843-851) | B7 human epitope |
IPRRIRQGL
|
gp160(843-851) | B*81 human epitope |
IPRRIRQGL
|
gp160(843-851) | C*05 human epitope |
IPRRIRQGA
|
gp160(843-851) | human epitope |
IPRRIRQGL
|
gp160(843-851) | human epitope |
IPRRIRQGf
|
gp160(843-851) | subtype-specific susceptible form |
IPTRIRQGL
|
gp160(843-851) | human epitope |
IPrRIRQGL
|
gp160(843-851) | observed variant |
IPRRIRQGF
|
gp160(843-851) | human epitope |
IPRRIRQGA
|
gp160(843-851) | human epitope |
IPRRIRQGF
|
gp160(843-851) | human epitope |
IPRRIRQGL
|
gp160(843-851) | human epitope |
IPRRIRQGL
|
gp160(843-851) | human epitope |
IPRRIRQGf
|
gp160(843-851) | subtype-specific susceptible form |
IvRRIRQGL
|
gp160(843-851) | subtype-specific susceptible form |
IPRRIRQGF
|
gp160(843-851) | human epitope |
IPRRIRQGL
|
gp160(843-851) | human epitope |
IPRRIRQGL
|
gp160(843-851) | human epitope |
IPRRIRQGLA
|
gp160(843-852) | B*07:02 human epitope |
RRIRQGLERILL
|
gp160(845-856) | A30, B8 human epitope |
RRIRQGLERILL
|
gp160(845-856) | B7, B8 human epitope |
RRIRQGLERILL
|
gp160(845-856) | human epitope |
RIRQGLERA
|
gp160(846-854) | A*02:05 human epitope |
RIRQGLERA
|
gp160(846-854) | A*02:05 human epitope |
RIRQGfERA
|
gp160(846-854) | observed variant |
RIRQGLEaA
|
gp160(846-854) | observed variant |
RIRQGfEaA
|
gp160(846-854) | observed variant |
RIRQGLfRA
|
gp160(846-854) | observed variant |
RIRQGLERA
|
gp160(846-854) | A*02:05 human epitope |
RIRQGLERA
|
gp160(846-854) | A*02:05 human epitope |
RIRQGLERA
|
gp160(846-854) | A2 human epitope |
RIRQGLERA
|
gp160(846-854) | A2 human epitope |
RIRQGLERA
|
gp160(846-854) | human epitope |
RIRQGLERALL
|
gp160(846-856) | human epitope |
IRQGLERAL
|
gp160(847-855) | B*27:02 human epitope |
IRQGLERAL
|
gp160(847-855) | B*27:05 human epitope |